z-logo
Premium
Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis
Author(s) -
Michikawa Makoto,
Yanagisawa Katsuhiko
Publication year - 1998
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/(sici)1097-4547(19981001)54:1<58::aid-jnr7>3.0.co;2-g
Subject(s) - cholesterol , apolipoprotein b , programmed cell death , cholesterol synthesis , chemistry , microbiology and biotechnology , biology , biochemistry , apoptosis , enzyme , reductase
The presence of the apolipoprotein E (apoE) allele ϵ4 is a major risk factor for the development of Alzheimer's disease (AD); however, the molecular mechanism underlying the acceleration of AD development in individuals with ϵ4 remains to be determined. To investigate the isoform‐specific effects of apoE on neurons, primary neuron cultures were prepared from fetal rat cerebral cortices. Inhibition by compactin, a 3‐hydroxyl‐3‐methylglutaryl coenzyme A reductase inhibitor of de novocholesterol synthesis, induced premature neuronal cell death in a dose‐dependent manner. In the presence of compactin at a sublethal dose to the cells, rabbit β‐migrating very low density lipoprotein (β‐VLDL) with human apoE4 (the product of ϵ4) induced premature neuronal cell death, while that with apoE3 (the product of ϵ3) did not. Neurons cultured in the presence of apoE4, β‐VLDL, and compactin were shrunken and spherical, containing condensed chromatin and fragmented DNA, features characteristic of apoptosis. The addition of intermediate metabolites of the cholesterol biosynthetic pathway, including mevalonate and squalene, rescued neuronal cells incubated with apoE4 and β‐VLDL, in the presence of compactin. These results strongly suggest that a reduction in the level of endogenously synthesized cholesterol is a prerequisite for apoE4‐induced neuronal cell death. J. Neurosci. Res. 54:58–67, 1998. © 1998 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here